Evaluation of the Efficacy and Safety of the Sullivan Cochlear Implant.

NCT07018882 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2025-06-13

No results posted yet for this study

Summary

The study will be conducted as a prospective, single center, repeat measure, single-arm, open label clinical study

Conditions

  • Hearing Loss, Sensorineural

Interventions

DEVICE

Sullivan

Patients who are clinically eligible for cochlear implant surgery and can tolerate the surgery will be asked for their consent and then undergo the cochlear implant procedure. The outcome of the cochlear implant surgery will be evaluated through auditory performance assessments. Additionally, adverse effects will be monitored to assess the efficacy and safety of the cochlear implants on auditory function.

Sponsors & Collaborators

  • Samsung Medical Center

    collaborator OTHER
  • Todoc

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-30
Primary Completion
2026-12-31
Completion
2026-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07018882 on ClinicalTrials.gov